Close
Help
Login
Staff Login
Register
FR
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Hide details
Conceptually similar
CP121584821 | Canada probing J&J vaccine blood-clot reports
CP122404571 | Quebec reports first blood clot death in woman who received AstraZeneca vaccine
CP121585560 | Newsroom Ready: Canada probing J&J vaccine blood-clot reports
CP122830710 | New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine
CP122152571 | US resumes J&J vaccinations despite rare clot risk
CP122904771 | B.C. records first case of rare blood clot related to vaccine
CP121579471 | US recommends 'pause' for J&J vaccine over clots
CP129984473 | Alberta woman survives deadly COVID blood clot
CP121601421 | Colorado among US states to pause JandJ vaccine
CP122017117 | AstraZeneca blood clot risk remains low: Tam
Probe after blood clot death linked to vaccine
Oregon health officials said Thursday that federal officials are investigating the death of a woman in her 50s who developed a rare blood clot and low platelets within two weeks of receiving the Johnson & Johnson vaccine against COVID-19. (April 22)
Actions
Add to collection
Add to cart
Information
Source name:
The Associated Press
Unique identifier:
CP122094921
Legacy Identifier:
c40b1606e1404e70bc1292ea3bed162d
Type:
Video
Duration:
56s
Dimensions:
1920px × 1080px 68.88 MB
Usage rights:
Digital platform use only. Broadcast rights and editing of content prohibited.
Create Date:
4/22/2021 8:40:33 PM
Display aspect ratio:
16:9